However, it is worth noting that the development of DYRK1A inhibitors may be beneficial in the treatment of other diseases, including neurological disorders such as Alzheimer’s Disease(AD), Parkinson’s and Huntington’s diseases, Down Syndrome (DS) [79] and cancer [20]. This evidence concerns the gene DYRK1A and Dravet syndrome.